AMED
Amedisys, Inc.
Every pitch and position made on this ticker, across every competition and newsletter issue in the archive.
- Times pitched
- 2
- Long / short
- 2 / 0
- Avg. return
- -88.9%
- Verdicts
- Failed 1 Inconclusive 1
pitch
Fall 2009
Ken Leslie
long
-88.9%
failed
Newsletter
The current AMED share price implies little to no revenue growth due to concerns over Medicare reimbursement reform. However, Amedisys is positioned for growth through acquisitions, a strong pipeline
position
Fall 2009
Graham & Doddsville
long
inconclusive
Newsletter
Amedisys is well-positioned in the healthcare sector, particularly in home health care, which is expected to grow due to an aging population and increasing demand for at-home services.